UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Retrovirology, 2018-08, Vol.15 (1), p.56-56, Article 56

2018

Volltextzugriff (PDF)

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

AIDS (London), 2017-06, Vol.31 (10), p.1425-1434

2017

Volltextzugriff (PDF)

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

The Journal of clinical investigation, 2009-03, Vol.119 (3), p.661-673

2009

Volltextzugriff (PDF)

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

The Lancet (British edition), 2010-05, Vol.375 (9729), p.1896-1905

2010

Volltextzugriff (PDF)

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation

Human gene therapy, 2008-10, Vol.19 (10), p.991-999

2008

Volltextzugriff (PDF)

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

Science translational medicine, 2014-08, Vol.6 (250), p.250ra116

2014

Volltextzugriff (PDF)

Stable expression of shRNAs in human CD34 + progenitor cells can avoid induction of interferon responses to siRNAs in vitro

Nature biotechnology, 2006-05, Vol.24 (5), p.566-571

2006

Volltextzugriff (PDF)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

Open forum infectious diseases, 2019-03, Vol.6 (3), p.ofz060-ofz060

2019

Volltextzugriff (PDF)

Molecular aspects of plant virus transmission by Olpidium and plasmodiophorid vectors

Annual review of phytopathology, 2004-01, Vol.42 (1), p.211-241

2004

Volltextzugriff (PDF)

Sensing the danger in RNA

Nature medicine, 2005-03, Vol.11 (3), p.250-251

2005

Volltextzugriff (PDF)

2′-O-methyl-modified RNAs Act as TLR7 Antagonists

Molecular therapy, 2007-09, Vol.15 (9), p.1663-1669

2007

Volltextzugriff (PDF)

Evidence that Binding of Cucumber Necrosis Virus to Vector Zoospores Involves Recognition of Oligosaccharides

Journal of Virology, 2003-04, Vol.77 (7), p.3922-3928

2003

Volltextzugriff (PDF)

Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2829-2829

2011

Volltextzugriff (PDF)

Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)

Blood, 2023-11, Vol.142 (Supplement 1), p.5754-5754

2023

Volltextzugriff (PDF)

A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Blood, 2022-11, Vol.140 (Supplement 1), p.11761-11762

2022

Volltextzugriff (PDF)

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Blood, 2022-11, Vol.140 (Supplement 1), p.6235-6236

2022

Volltextzugriff (PDF)

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Blood, 2023-11, Vol.142 (Supplement 1), p.2870-2870

2023

Volltextzugriff (PDF)

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Leukemia & lymphoma, 2024-07, Vol.65 (8), p.1127-1135

2024

Volltextzugriff (PDF)

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

The Journal of clinical investigation, 2017-12, Vol.127 (12), p.4437-4448

2017

Volltextzugriff (PDF)

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Leukemia & lymphoma, 2024-04, p.1

2024

Volltextzugriff (PDF)

ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S276-S276

2021

Volltextzugriff (PDF)

Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Clinical lymphoma, myeloma and leukemia, 2021-09, Vol.21, p.S208-S208

2021

Volltextzugriff (PDF)

siRNA and innate immunity

Oligonucleotides, 2009-06, Vol.19 (2), p.89-102

2009

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Englisch
(69)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Humans
(21)
Animals
(16)
Biological And Medical Sciences
(10)
Female
(9)
Male
(9)
Mice
(9)
Fundamental And Applied Biological Sciences. Psychology
(7)
Medical Sciences
(6)
Medicine, Research & Experimental
(6)
Research & Experimental Medicine
(6)
Rna, Small Interfering - Genetics
(6)
Adult
(5)
Disease Models, Animal
(5)
Liquids
(5)
Rna Interference
(5)
Social Sciences
(5)
Virology
(5)
Antibacterials
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir

Emergent drug resistance with integrase strand transfer inhibitor-based regimens

Confirming the RNAi-mediated mechanism of action of siRNA-based cancer therapeutics in mice

Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study

Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation

Venetoclax in combination with a pediatric-inspired regimen for the treatment of newly diagnosed adults with Philadelphia chromosome-negative acute lymphoblastic leukemia

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA

Stable expression of shRNAs in human CD34 + progenitor cells can avoid induction of interferon responses to siRNAs in vitro

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis

Molecular aspects of plant virus transmission by Olpidium and plasmodiophorid vectors

Sensing the danger in RNA

2′-O-methyl-modified RNAs Act as TLR7 Antagonists

Evidence that Binding of Cucumber Necrosis Virus to Vector Zoospores Involves Recognition of Oligosaccharides

Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1

Pharmacology of a CpG-Linked Anti-Mir-126 Oligonucleotide Targeting Acute Myeloid Leukemia (AML) in Rats and Non-Human Primates (NHP)

A Phase 1b Study of IDH Inhibition with Enasidenib and MEK Inhibition with Cobimetinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia Who Have Co-Occurring IDH2 and RAS Signaling Gene Mutations

Promising Safety and Efficacy Results from an Ongoing Phase 1b Study of Pembrolizumab Combined with Decitabine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

A Phase 1 Study of Venetoclax in Combination with a Pediatric-Inspired Regimen for the Treatment of Newly Diagnosed Adults with B-Cell Ph-like ALL

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

Interim Results of a Phase 1/2 Study of Pembrolizumab Combined with Blinatumomab in Patients with Relapsed/Refractory (r/r) ALL

siRNA rescues nonhuman primates from advanced Marburg and Ravn virus disease

Flotetuzumab as a salvage immunotherapy in advanced CD123-positive hematological malignancies, a phase 1 pilot study

ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

Poster: ALL-440: Promising Safety and Efficacy Results from an Ongoing Phase 1/2 Study of Pembrolizumab in Combination with Blinatumomab in Patients (pts) with Relapsed or Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)

siRNA and innate immunity

Aktive Filter

Suchergebnisse filtern